Literature DB >> 30691798

A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma.

Wen-Jie Wang1, Hong-Tao Li1, Jian-Ping Yu1, Xiao-Peng Han1, Zi-Peng Xu1, Yu-Min Li2, Zuo-Yi Jiao3, Hong-Bin Liu4.   

Abstract

BACKGROUND: Accumulating evidence indicated that long noncoding RNAs (lncRNAs) have a wide range of biological functions and may play significant roles in tumorigenesis and progression. However, the understanding of its functions and related competitive endogenous RNAs (ceRNAs) networks is much less than that of protein-coding genes, particularly in colon adenocarcinoma.
METHODS: We comprehensively analyzed the sequencing data of protein-coding and noncoding RNAs in colon adenocarcinoma patients from The Cancer Genome Atlas (TCGA) database. Next, we constructed colon adenocarcinoma-specific ceRNA network and evaluated the effect of these RNAs on overall survival (OS) for colon adenocarcinoma patients.
RESULTS: Totally, 1138 differentially expressed lncRNAs (DElncRNAs), 245 microRNAs (DEmiRNAs), and 2081 mRNAs (DEmRNAs) were identified using a threshold of |log2FoldChange| >2.0 and adjusted P-value < 0.01. Subsequently, a colon adenocarcinoma-specific ceRNA network was successfully established with133 DElncRNAs, 29 DEmiRNAs, and 55 DEmRNAs. Among ceRNA network, seven DElncRNAs (AL590483.1, AP004609.1, ARHGEF26-AS1, HOX transcript antisense RNA (HOTAIR), ITCH-IT1, KCNQ1OT1, and LINC00491), four DEmiRNAs (hsa-mir-143, hsa-mir-183, hsa-mir-216a, and hsa-mir-424), and six DEmRNAs (FJX1, TPM2, ULBP2, PDCD4, PLAU, and SERPINE1) significantly correlated with OS (all P-value < 0.05). Notably, several interactions were highlighted in the ceRNA network, such as "KCNQ1OT1-hsa-mir-183-PDCD4", "KCNQ1OT1-hsa-mir-424-TPM2", "HOTAIR-hsa-mir-143-SERPINE1", and "ARHGEF26-AS1-hsa-mir-143-SERPINE1".
CONCLUSIONS: These findings reveal several molecules might be novel important prognostic factors and potential treatment targets for colon adenocarcinoma. In addition, these observations contribute to a more comprehensive understanding of lncRNA-related ceRNA network and provide novel strategies for subsequent functional studies of lncRNAs in colon adenocarcinoma.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colon adenocarcinoma; Competing endogenous RNA network; Long noncoding RNAs; Prognosis; mRNA; microRNAs

Mesh:

Substances:

Year:  2018        PMID: 30691798     DOI: 10.1016/j.jss.2018.09.053

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  21 in total

1.  Long non-coding RNA SLC25A25-AS1 exhibits oncogenic roles in non-small cell lung cancer by regulating the microRNA-195-5p/ITGA2 axis.

Authors:  Jinqin Chen; Chengpeng Gao; Wei Zhu
Journal:  Oncol Lett       Date:  2021-05-16       Impact factor: 2.967

2.  SOX21-AS1 is associated with clinical stage and regulates cell proliferation in nephroblastoma.

Authors:  Jingxiu Zhang; Tianzhao Hou; Xueliang Qi; Jihong Wang; Xiangguo Sun
Journal:  Biosci Rep       Date:  2019-05-17       Impact factor: 3.840

3.  Cancer-related long noncoding RNAs show aberrant expression profiles and competing endogenous RNA potential in esophageal adenocarcinoma.

Authors:  Yang Yu; Xingxing Chen; Shundong Cang
Journal:  Oncol Lett       Date:  2019-09-05       Impact factor: 2.967

4.  LncRNA TINCR favors tumorigenesis via STAT3-TINCR-EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer.

Authors:  Qin Wang; Jiena Liu; Zilong You; Yanling Yin; Lei Liu; Yujuan Kang; Siwei Li; Shipeng Ning; Hui Li; Yajie Gong; Shouping Xu; Da Pang
Journal:  Cell Death Dis       Date:  2021-01-14       Impact factor: 8.469

5.  LINC00491 as a new molecular marker can promote the proliferation, migration and invasion of colon adenocarcinoma cells.

Authors:  Jiahui Wan; Daiqian Deng; Xiuli Wang; Xiaojin Wang; Shijun Jiang; Rongjun Cui
Journal:  Onco Targets Ther       Date:  2019-08-13       Impact factor: 4.147

6.  Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma.

Authors:  Dongkai Zhou; Bingqiang Gao; Qifan Yang; Yang Kong; Weilin Wang
Journal:  Biomed Res Int       Date:  2019-11-25       Impact factor: 3.411

Review 7.  The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.

Authors:  Ling Wei; Xingwu Wang; Liyan Lv; Jibing Liu; Huaixin Xing; Yemei Song; Mengyu Xie; Tianshui Lei; Nasha Zhang; Ming Yang
Journal:  Mol Cancer       Date:  2019-10-25       Impact factor: 27.401

Review 8.  Noncoding RNAs in gastric cancer: implications for drug resistance.

Authors:  Ling Wei; Jujie Sun; Nasha Zhang; Yan Zheng; Xingwu Wang; Liyan Lv; Jiandong Liu; Yeyang Xu; Yue Shen; Ming Yang
Journal:  Mol Cancer       Date:  2020-03-19       Impact factor: 27.401

9.  Long-Chain Non-Coding SOX21-AS1 Promotes Proliferation and Migration of Breast Cancer Cells Through the PI3K/AKT Signaling Pathway.

Authors:  Xiu-Yun Sheng; Cheng-Hong Wang; Chun-Feng Wang; Hong-Yan Xu
Journal:  Cancer Manag Res       Date:  2020-11-02       Impact factor: 3.989

10.  Biomarker Discovery for the Carcinogenic Heterogeneity Between Colon and Rectal Cancers Based on lncRNA-Associated ceRNA Network Analysis.

Authors:  Xin Qi; Yuxin Lin; Xingyun Liu; Jiajia Chen; Bairong Shen
Journal:  Front Oncol       Date:  2020-10-30       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.